A number of randomized clinical trials have compared the paleo diet to other eating plans, such as the Mediterranean Diet or the Diabetes Diet. Overall, these trials suggest that a paleo diet may provide some benefits when compared with diets of fruits, vegetables, lean meats, whole grains, legumes and low-fat dairy products. These benefits may include:
Most of these recipes give us enough dinner for our family and then leftovers for my husband and I (I make a separate lunch for the kids most times). If you both eat normal-sized portions, you would probably be fine to cut it in half and have enough for leftovers. But if you tend to eat larger portions, I’d err on the side of caution and just go with the full amount.
While founders Dallas Hartwig and Melissa Hartwig are adamant in their book and on their website that “you’ve done harder things than this, and you have no excuse not to complete the program as written,” the Whole30 is not for the lazy or noncommittal. Without careful planning, a strong support system and dogged dedication, a business lunch, flight delay or date night can throw you off and send you back to the start. By nature, diets that eliminate entire food groups are tough to follow. On the other hand, it’s only 30 days.
Workout 4A & 4B has an 11 min time cap. It is a chipper that begins with the athlete standing tall behind their measured handstand-pushup box. At the start of the ascending clock, the athlete will kick up to a locked out handstand before performing their repetitions. They will then move onto the pull-ups and complete 50 repetitions before moving to the toes to bar to complete another 50 repetitions, and lastly onto the wall-balls, complete 50 repetitions. Athletes may take as many sets, breaking up the work as needed, to complete the required number of repetitions throughout the workout.
The WHO trial (so named because the international team of principal investigators contained World Health Organization members) tested the potential of clofibrate, a “pre-statin” cholesterol-lowering agent, to reduce heart attack morbidity and mortality. The investigators ultimately concluded that clofibrate "cannot be recommended as a lipid-lowering drug for community-wide primary prevention of ischaemic heart disease.” Nevertheless, clofibrate remained in use until 2002, when it was pulled for increasing cancer rates. In their review of studies such as the WHO trial, Uffe Ravnskov and David Diamond observe, “Despite the largely disappointing findings from 50 years of cholesterol lower[ing] trials, the indictment and conviction of cholesterol as the causal agent in CVD [cardiovascular disease] has stood the test of time. … [Yet] the grand effort to reduce cholesterol as a strategy to improve health has failed.”